On October 19, the U.S. Food and Drug Administration (FDA) amended the Novavax COVID-19 Vaccine, Adjuvanted emergency use authorization to authorize the use of a first booster dose for patients 18 years and older:
- For whom an FDA-authorized bivalent (updated) booster isn’t accessible or clinically appropriate
- Who choose to get the Novavax booster because they wouldn’t otherwise get a COVID-19 booster
Use the new CPT code effective October 19, 2022:
Code 0044A for Novavax Covid-19 Vaccine, Adjuvanted – Administration – Booster Dose:
- Long descriptor: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5 mL dosage; booster dose
- Short descriptor: ADM SARSCOV2 5MCG/0.5ML BST
Source: U.S. Centers for Medicare & Medicaid Services (CMS)
3Gen Consulting has always been in the forefront when it comes to adding value. We always believe in setting our own standards. What sets us apart is the investment that we make in our people, processes and innovation to provide you with market leading healthcare revenue cycle management services. We work as an extension of our clients’ teams by focusing on their key challenges, aligning with their culture and delivering the best results.
If you’re interested in finding the right medical billing and coding services partner, contact us today.